Literature DB >> 17046823

Involvement of GSK-3beta and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells.

Fumi Takahashi-Yanaga1, Jun Mori, Etsuko Matsuzaki, Yutaka Watanabe, Masato Hirata, Yoshikazu Miwa, Sachio Morimoto, Toshiyuki Sasaguri.   

Abstract

Differentiation-inducing factors (DIFs) are putative morphogens that induce cell differentiation in Dictyostelium discoideum. We previously reported that DIF-3 activates glycogen synthase kinase-3beta (GSK-3beta), resulting in the degradation of cyclin D1 in HeLa cells. In this study, we investigated the effect of DIF-3 on cyclin D1 mutants (R29Q, L32A, T286A, T288A, and T286A/T288A) to clarify the precise mechanisms by which DIF-3 degrades cyclin D1 in HeLa cells. We revealed that T286A, T288A, and T286A/T288A mutants were resistant to DIF-3-induced degradation compared with wild-type cyclin D1, indicating that the phosphorylation of Thr(286) and Thr(288) were critical for cyclin D1 degradation induced by DIF-3. Indeed, DIF-3 markedly elevated the phosphorylation level of cyclin D1, and mutations introduced to Thr(286) and/or Thr(288) prevented the phosphorylation induced by DIF-3. Depletion of endogenous GSK-3beta and dual-specificity tyrosine phosphorylation regulated kinase 1B (DYRK1B) by RNA interference attenuated the DIF-3-induced cyclin D1 phosphorylation and degradation. The effect of DIF-3 on DYRK1B activity was examined and we found that DIF-3 also activated this kinase. Further, we found that not only GSK-3beta but also DYRK1B modulates cyclin D1 subcellular localization by the phosphorylation of Thr(288). These results suggest that DIF-3 induces degradation of cyclin D1 through the GSK-3beta- and DYRK1B-mediated threonine phosphorylation in HeLa cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046823     DOI: 10.1074/jbc.M605205200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Dosage of Dyrk1a shifts cells within a p21-cyclin D1 signaling map to control the decision to enter the cell cycle.

Authors:  Jia-Yun Chen; Jia-Ren Lin; Feng-Chiao Tsai; Tobias Meyer
Journal:  Mol Cell       Date:  2013-10-10       Impact factor: 17.970

2.  Depleting Mirk Kinase Increases Cisplatin Toxicity in Ovarian Cancer Cells.

Authors:  Jing Hu; Eileen Friedman
Journal:  Genes Cancer       Date:  2010-08-01

3.  The WD40-repeat protein Han11 functions as a scaffold protein to control HIPK2 and MEKK1 kinase functions.

Authors:  Stefanie Ritterhoff; Carla M Farah; Julia Grabitzki; Günter Lochnit; Alexander V Skurat; Michael Lienhard Schmitz
Journal:  EMBO J       Date:  2010-10-12       Impact factor: 11.598

Review 4.  Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer.

Authors:  Lina Sabatino; Massimo Pancione; Carolina Votino; Tommaso Colangelo; Angelo Lupo; Ettore Novellino; Antonio Lavecchia; Vittorio Colantuoni
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

5.  Mirk/Dyrk1B maintains the viability of quiescent pancreatic cancer cells by reducing levels of reactive oxygen species.

Authors:  Xiaobing Deng; Daina Z Ewton; Eileen Friedman
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

6.  Mirk regulates the exit of colon cancer cells from quiescence.

Authors:  Kideok Jin; Daina Z Ewton; Sunju Park; Jing Hu; Eileen Friedman
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

7.  Enhanced Akt/GSK-3β/CREB signaling mediates the anti-inflammatory actions of mGluR5 positive allosteric modulators in microglia and following traumatic brain injury in male mice.

Authors:  Shahnawaz A Bhat; Rebecca J Henry; Alexa C Blanchard; Bogdan A Stoica; David J Loane; Alan I Faden
Journal:  J Neurochem       Date:  2020-01-28       Impact factor: 5.546

Review 8.  The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention.

Authors:  John P Alao
Journal:  Mol Cancer       Date:  2007-04-02       Impact factor: 27.401

9.  DIF-1 inhibits growth and metastasis of triple-negative breast cancer through AMPK-mediated inhibition of the mTORC1-S6K signaling pathway.

Authors:  Fumi Seto-Tetsuo; Masaki Arioka; Koichi Miura; Takeru Inoue; Kazunobu Igawa; Katsuhiko Tomooka; Fumi Takahashi-Yanaga; Toshiyuki Sasaguri
Journal:  Oncogene       Date:  2021-07-24       Impact factor: 9.867

Review 10.  Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control.

Authors:  Walter Becker
Journal:  Cell Cycle       Date:  2012-08-23       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.